FDA Waits For NDI Notifications Increase On Tail Of 'No Objection' Uptick
This article was originally published in The Rose Sheet
Executive Summary
FDA has seen an uptick in “acknowledgement with no objection” response letters to dietary supplement firms' s NDI notifications, but says those positive responses still account for only a quarter of all its responses.